Targeted disruption of the murine homeodomain-interacting protein kinase-2 causes growth deficiency in vivo and cell cycle arrest in vitro

  • Francesco Trapasso
  • , Rami I. Aqeilan
  • , Rodolfo Iuliano
  • , Rosa Visone
  • , Eugenio Gaudio
  • , Laura Ciuffini
  • , Hansjuerg Alder
  • , Francesco Paduano
  • , Giovanna Maria Pierantoni
  • , Silvia Soddu
  • , Carlo M. Croce
  • , Alfredo Fusco*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

The homeodomain-interacting protein kinase 2 (HIPK2) protein is a member of a recently identified family of nuclear protein kinases that are well conserved in various organisms. HIPK2 can bind to several homeotic factors and to a series of proteins involved in the regulation of cell survival and proliferation in response to morphogenetic and genotoxic signals. Here we report Hipk2-targeted disruption in mouse; Hipk2-/- mice are viable and fertile but significantly smaller than their wild-type littermates. This feature is present at birth and retained throughout the mouse adulthood. Mouse embryo fibroblasts from Hipk2-/- mice show a reduced proliferation rate, compared to the wild-type counterparts, with accumulation in the G0/G1 phase of the cell cycle and altered levels of the cell cycle regulators cyclin D and CDK6. Restoration of wild-type HIPK2 expression in Hipk2-/- cells rescues the normal phenotype supporting a role for HIPK2 in the regulation of cell proliferation.

Original languageEnglish
Pages (from-to)161-167
Number of pages7
JournalDNA and Cell Biology
Volume28
Issue number4
DOIs
StatePublished - 1 Apr 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'Targeted disruption of the murine homeodomain-interacting protein kinase-2 causes growth deficiency in vivo and cell cycle arrest in vitro'. Together they form a unique fingerprint.

Cite this